B3Z-19363-86012
4 vaccinations
14 coded responses
35 check-ins
13 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 220 / VA
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Registered in v-safe
-
2021-01-11
Dose 1 — Pfizer-BioNTech
-
2021-01-11
Survey response — day 0, dose 1MedDRA: Chest pain — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Mild chest painsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Chills, Fatigue or tirednessAdult check-in
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Chest pain — Feeling: Good · Fatigue or tirednessFree text: Chest pain along sternumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — days 1–6 daily, dose 1MedDRA: Chest pain — Feeling: Fair · Fatigue or tirednessFree text: Mild chest painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-17
- 2021-01-18
-
2021-01-25
Survey response — day 14, dose 1MedDRA: Chills, Rhinorrhoea — Feeling: FairFree text: Chills, runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — day 21, dose 1MedDRA: Dyspnoea — Feeling: GoodFree text: Shortness of breath while talking. Feel very winded during and after conversations. Have sometimes needed to pause talking to take a deep breath. When i check my sp02 levels its still >97%MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Fatigue or tirednessAdult check-in
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-10
-
2021-02-17
Survey response — day 14, dose 2MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-24
-
2021-03-03
Survey response — day 28, dose 2MedDRA: Increased appetite, Weight increased — Feeling: FairFree text: Increased appetite, weight gainMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
- 2021-03-17
-
2021-05-05
Survey response — 3 months, dose 2MedDRA: Dyspnoea, Weight increased — Feeling: FairFree text: Weight gain, some mild shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-07
Survey response — 6 months, dose 2MedDRA: Condition aggravated, Migraine, Nausea, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Migraines with nausea, flare of ulcerative colitis conditionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-07
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-11-24
Call successfulDoes not wish to fill out VAERS report
-
2021-12-13
Dose 3 — Pfizer-BioNTech
- 2021-12-13
-
2021-12-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessAdult check-in
-
2021-12-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-12-17
Survey response — days 1–6 daily, dose 3MedDRA: Paraesthesia — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Abdominal painFree text: Tingling in right leg and footMedDRA releases: 2024-11 · check-in free text available
-
2021-12-19
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
- 2021-12-20
- 2021-12-27
-
2022-01-04
Survey response — day 21, dose 3MedDRA: Migraine — Feeling: Fair · Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2024-11 · check-in free text available
- 2022-01-10
- 2022-01-17
-
2022-01-24
Survey response — day 42, dose 3MedDRA: Acne, Increased appetite, Weight increased — Feeling: FairFree text: Weight gain, acne, increased appetiteMedDRA releases: 2024-11 · check-in free text available
- 2022-03-14
-
2022-06-15
Survey response — 6 months, dose 3MedDRA: Colitis ulcerative, Diarrhoea haemorrhagic — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Bloody diarrhea - ulcerative colitisMedDRA releases: 2024-11 · check-in free text available
-
2022-06-15
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-06-16
- 2022-06-16
-
2022-09-11
Dose 4 — Pfizer-BioNTech
-
2023-03-12
Survey response — 6 months, dose 4MedDRA: Arthralgia, Muscle strain — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech | |
| 3 | 2021-12-13 | Pfizer-BioNTech | No |
| 4 | 2022-09-11 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Mild chest pains
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Chest pain along sternum
Systemic reaction (other): Mild chest pain
Release 2 — day 14, dose 1
Symptoms: Chills, runny nose
Release 3 — day 21, dose 1
Symptoms: Shortness of breath while talking. Feel very winded during and after conversations. Have sometimes needed to pause talking to take a deep breath. When i check my sp02 levels its still >97%
Release 4 — day 14, dose 2
Symptoms: Fatigue
Release 5 — day 28, dose 2
Symptoms: Increased appetite, weight gain
Release 8 — 3 months, dose 2
Symptoms: Weight gain, some mild shortness of breath
Release 9 — 6 months, dose 2
Symptoms: Migraines with nausea, flare of ulcerative colitis condition
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Tingling in right leg and foot
Release 10 — day 21, dose 3
Symptoms: Migraine
Release 11 — day 42, dose 3
Symptoms: Weight gain, acne, increased appetite
Release 12 — 6 months, dose 3
Symptoms: Bloody diarrhea - ulcerative colitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Acne | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Colitis ulcerative | · | · | ✓ |
| SD | Condition aggravated | ✓ | · | ✓ |
| SD | Diarrhoea haemorrhagic | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Increased appetite | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | · | ✓ |
| SD | Muscle strain | · | · | ✓ |
| SD | Nausea | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Weight increased | ✓ | ✓ | ✓ |
| SRO | Chest pain | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release